Search

Mitchell Hill

Examiner (ID: 115)

Most Active Art Unit
3106
Art Unit(s)
2899, 3106
Total Applications
1496
Issued Applications
1329
Pending Applications
6
Abandoned Applications
161

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4156073 [patent_doc_number] => 06124431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Peptide derivatives' [patent_app_type] => 1 [patent_app_number] => 9/039426 [patent_app_country] => US [patent_app_date] => 1998-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6098 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124431.pdf [firstpage_image] =>[orig_patent_app_number] => 039426 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/039426
Peptide derivatives Mar 15, 1998 Issued
Array ( [id] => 4071999 [patent_doc_number] => 06069129 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Elastin derived composition and method of using same' [patent_app_type] => 1 [patent_app_number] => 9/039308 [patent_app_country] => US [patent_app_date] => 1998-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 7664 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069129.pdf [firstpage_image] =>[orig_patent_app_number] => 039308 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/039308
Elastin derived composition and method of using same Mar 12, 1998 Issued
Array ( [id] => 4183919 [patent_doc_number] => 06150332 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Method and composition for lowering low density lipoprotein cholesterol' [patent_app_type] => 1 [patent_app_number] => 9/038935 [patent_app_country] => US [patent_app_date] => 1998-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3955 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150332.pdf [firstpage_image] =>[orig_patent_app_number] => 038935 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/038935
Method and composition for lowering low density lipoprotein cholesterol Mar 11, 1998 Issued
09/038432 DERIVATIVES OF GLP-1 ANALOGS Mar 10, 1998 Abandoned
Array ( [id] => 4410177 [patent_doc_number] => 06228840 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Melanocortin receptor antagonists and modulations of melanocortin receptor activity' [patent_app_type] => 1 [patent_app_number] => 9/031902 [patent_app_country] => US [patent_app_date] => 1998-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7683 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228840.pdf [firstpage_image] =>[orig_patent_app_number] => 031902 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/031902
Melanocortin receptor antagonists and modulations of melanocortin receptor activity Feb 26, 1998 Issued
09/031122 ANTIBACTERIAL DRUGS, METHODS FOR THEIR DESIGN AND METHODS FOR THEIR USE Feb 25, 1998 Abandoned
Array ( [id] => 4156019 [patent_doc_number] => 06103699 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Peptide, a method for its preparation and a pharmaceutical composition containing the peptide' [patent_app_type] => 1 [patent_app_number] => 9/032550 [patent_app_country] => US [patent_app_date] => 1998-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9421 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103699.pdf [firstpage_image] =>[orig_patent_app_number] => 032550 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/032550
Peptide, a method for its preparation and a pharmaceutical composition containing the peptide Feb 25, 1998 Issued
08/952972 PEPTIDE FRAGMENTS OF TISSUE FACTOR AND THEIR USE FOR TREATMENT AND PREVENTION OF CLOTTING DISORDERS Feb 23, 1998 Abandoned
Array ( [id] => 3945957 [patent_doc_number] => 05998376 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Substance P treatment for immunostimulation' [patent_app_type] => 1 [patent_app_number] => 9/028003 [patent_app_country] => US [patent_app_date] => 1998-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 6671 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/998/05998376.pdf [firstpage_image] =>[orig_patent_app_number] => 028003 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/028003
Substance P treatment for immunostimulation Feb 22, 1998 Issued
Array ( [id] => 4059395 [patent_doc_number] => 06007804 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'IL-6 as serum uric acid decreasing compound' [patent_app_type] => 1 [patent_app_number] => 9/027618 [patent_app_country] => US [patent_app_date] => 1998-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2077 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/007/06007804.pdf [firstpage_image] =>[orig_patent_app_number] => 027618 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/027618
IL-6 as serum uric acid decreasing compound Feb 22, 1998 Issued
Array ( [id] => 4267865 [patent_doc_number] => 06245502 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Target system' [patent_app_type] => 1 [patent_app_number] => 9/026904 [patent_app_country] => US [patent_app_date] => 1998-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 10383 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245502.pdf [firstpage_image] =>[orig_patent_app_number] => 026904 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/026904
Target system Feb 18, 1998 Issued
Array ( [id] => 4088990 [patent_doc_number] => 06133233 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Peptide modulation of reperfusion injury' [patent_app_type] => 1 [patent_app_number] => 9/024975 [patent_app_country] => US [patent_app_date] => 1998-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5360 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133233.pdf [firstpage_image] =>[orig_patent_app_number] => 024975 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/024975
Peptide modulation of reperfusion injury Feb 15, 1998 Issued
Array ( [id] => 4207915 [patent_doc_number] => 06028056 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Pharmaceutical compositions for imaging and treating thrombi' [patent_app_type] => 1 [patent_app_number] => 9/020086 [patent_app_country] => US [patent_app_date] => 1998-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3644 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028056.pdf [firstpage_image] =>[orig_patent_app_number] => 020086 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/020086
Pharmaceutical compositions for imaging and treating thrombi Feb 5, 1998 Issued
Array ( [id] => 3949507 [patent_doc_number] => 05955431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Mast cell protease peptide inhibitors' [patent_app_type] => 1 [patent_app_number] => 9/016366 [patent_app_country] => US [patent_app_date] => 1998-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20599 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955431.pdf [firstpage_image] =>[orig_patent_app_number] => 016366 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/016366
Mast cell protease peptide inhibitors Jan 29, 1998 Issued
09/016346 METHODS AND COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS Jan 29, 1998 Abandoned
09/015394 ABSORBABLE MICROPARTICLES Jan 28, 1998 Abandoned
Array ( [id] => 4373262 [patent_doc_number] => 06288216 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Process for isolating a protein composition from a muscle source and protein composition' [patent_app_type] => 1 [patent_app_number] => 9/015760 [patent_app_country] => US [patent_app_date] => 1998-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10108 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288216.pdf [firstpage_image] =>[orig_patent_app_number] => 015760 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/015760
Process for isolating a protein composition from a muscle source and protein composition Jan 28, 1998 Issued
08/983632 USE OF NEURONAL CALCIUM CHANNEL BLOCKERS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF PSYCHOSES, SCHIZOPHRENIA, AND COCAINE OR AMPHETAMINE ADDICTION Jan 22, 1998 Abandoned
09/000087 HETERODIMER PEPTIDES WITH IMMUNOMODULATORY EFFECT Jan 21, 1998 Abandoned
08/983583 METHIONINE, PENICILLAMINE AND CYSTEINE-ANALOGUE CONTAINING PEPTIDES HAVING IMMUNOMODULATING ACTIVITY Jan 21, 1998 Abandoned
Menu